Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-2225-2021 — MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data.

U.S. FDA — Device Enforcement · France · 2021-06-22 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-2225-2021
Date of alert
2021-06-22
Country / jurisdiction
France
Risk level
Class II
Risk type
recall
Brand
BioMerieux SA
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
03573026619244
Reported risk: Software anomaly - Under certain conditions, unwanted alterations to results could be applied when using the BCI Connect scripting feature.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.